Repligen Virtual Technical Seminar - EU
Gene Therapy 2.0:
Manufacturing Solutions that work
thursday, October 29, 2020
10:00 AM UTC
A surge in both the number and type of viral vector-based gene therapies underscores the need for a greater than 10 to 100-fold increase in manufacturing efficiency to meet a demand curve that is increasing each year. The magnitude of the capacity shortage is sufficiently large that construction of new facilities alone does not represent a full solution.
This virtual seminar reviews the primary drivers of change, learnings from early adopters of transformative technologies, evaluations of risk landscapes and collaborations to help set the standards for Gene Therapy Manufacturing 2.0. Topics will include upstream intensification, harvest clarification, chromatography, UF/DF filtration and analytics.